Beyond MRSA: the growing menace of hVISA and VISA.
Deepti
D
Bulchandani
Jagdish
J
Nachnani
Curtis
C
Fitzsimmons
Paul
P
Jost
Joseph
J
Brewer
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017576:Daptomycin / Q000627:therapeutic use*; D003646:Debridement; D015299:Discitis / Q000188:drug therapy* / Q000601:surgery; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010019:Osteomyelitis / Q000188:drug therapy* / Q000601:surgery; D012008:Recurrence; D019233:Retreatment; D013122:Spinal Diseases / Q000188:drug therapy* / Q000601:surgery; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000601:surgery; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000235:genetics; D013904:Thoracic Vertebrae; D014640:Vancomycin / Q000627:therapeutic use*; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D017576:Daptomycin